Company / Inventory
Harmony Biosciences Holdings, Inc. Inventory History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$5.4M
FY2025
5-year range
$4.3M / $7.2M
FY2021-FY2025
Trend
-25.6%
vs FY2024
Sector context
#96 of 105
Health Care
What the data says
Among 105 Health Care companies, Harmony Biosciences Holdings, Inc. is in the bottom 9% for inventory. Inventory has fluctuated over the past 7 years, ranging from $1M in FY2019 to $7M in FY2024.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of +7.0%.
Remained stable around $5M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +7.6%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 105This company $5.4M Sector average $885.3M
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.0%, indicating consistent growth.
- In FY2025, inventory decreased 25.6% year-over-year.
- Ranks #96 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2024.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.4M | -25.6% |
| FY2024 | $7.2M | +34.2% |
| FY2023 | $5.4M | +24.8% |
| FY2022 | $4.3M | -3.0% |
| FY2021 | $4.4M | +15.9% |
| FY2020 | $3.8M | +251.4% |
| FY2019 | $1.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026